IBM shares experienced a sharp 13% decline, putting February on track to be the company's worst monthly performance in more than 50 years, exceeding previous estimates of a 34-year low. This historic sell-off is primarily driven by the emergence of Anthropic’s Claude Code, which is viewed as a direct threat to IBM's core enterprise software and services business. Analysts suggest that this new AI tool could disrupt traditional revenue streams that have long anchored the company's valuation. The significant drop reflects a broader shift in investor sentiment as the market questions IBM's competitive moat against innovative AI startups. The company now faces mounting pressure to adapt its business model to survive increasingly sophisticated technological competition.
freemium.freemium.cta.signup
freemium.freemium.cta.signup_button